To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa0318
Peptide Name Sequence 13 from Patent US 7790171 B1
Sequence KETWEXWWTX
Sequence Length 10
Source Synthetic construct
Target Organism HIV
Patent Type Granted Patent
Publication Date 2010-09-07
Patent No US 7790171 B1
Family Info WO 2002/015661 A2, AU 2001/092153 A, WO 2002/015661 A8, WO 2002/015661 A3, EP 1311538 A2, EP 1311538 B1, AT 420103 T, DE 60137340 D1, US 7790171 B1, US 2011/0064793 A1
Patent Title Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase
Comment The 'X' at position 6 indicates Thr or Ala, and the 'X' at position 10 indicates Glu or Asp.
Abstract The invention is drawn to a novel class of drugs directed against HIV, comprising a peptide or analog comprising a decapeptide, said decapeptide containing (from N-terminus to the C-terminus) a basic amino acid in position 1, an acidic amino acid in positions 2 and 5, and a tryptophan in positions 4, 7, and 8, and to a method of treatment of HIV infections, in particular multidrug-resistant HIV infections.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.